Ausgabe 1/2012
Inhalt (38 Artikel)
Alcohol and bone: review of dose effects and mechanisms
D. B. Maurel, N. Boisseau, C. L. Benhamou, C. Jaffre
Calcitonin for treating acute and chronic pain of recent and remote osteoporotic vertebral compression fractures: a systematic review and meta-analysis
J. A. Knopp-Sihota, C. V. Newburn-Cook, J. Homik, G. G. Cummings, D. Voaklander
The effect of exercise on pQCT parameters of bone structure and strength in postmenopausal women—a systematic review and meta-analysis of randomized controlled trials
I. Polidoulis, J. Beyene, A. M. Cheung
Predictors of new and severe vertebral fractures: results from the HORIZON Pivotal Fracture Trial
R. Wustrack, E. Seeman, C. Bucci-Rechtweg, S. Burch, L. Palermo, D. M. Black
Association between incident and baseline vertebral fractures in European women: vertebral fracture assessment in the Osteoporosis and Ultrasound Study (OPUS)
L. Ferrar, C. Roux, D. Felsenberg, C-C. Glüer, R. Eastell
Excess body fat is associated with higher risk of vertebral deformities in older women but not in men: a cross-sectional study
L. L. Laslett, S. J. Just nee Foley, S. J. Quinn, T. M. Winzenberg, G. Jones
Fracture risk assessment without bone density measurement in routine clinical practice
W. D. Leslie, S. Morin, L. M. Lix, H. Johansson, A. Oden, E. McCloskey, J. A. Kanis
Impact of a centralized osteoporosis coordinator on post-fracture osteoporosis management: a cluster randomized trial
S. B. Jaglal, O. S. Donescu, V. Bansod, J. Laprade, K. Thorpe, G. Hawker, S. R. Majumdar, L. Meadows, S. M. Cadarette, A. Papaioannou, M. Kloseck, D. Beaton, E. Bogoch, M. Zwarenstein
Cost-effectiveness of the Concord Minimal Trauma Fracture Liaison service, a prospective, controlled fracture prevention study
M. S. Cooper, A. J. Palmer, M. J. Seibel
A meta-analysis of brief high-impact exercises for enhancing bone health in premenopausal women
O. O. Babatunde, J. J. Forsyth, C. J. Gidlow
Physical activity, calcium intake and childhood bone mineral: a population-based cross-sectional study
N. C. Harvey, Z. A. Cole, S. R. Crozier, M. Kim, G. Ntani, L. Goodfellow, S. M. Robinson, H. M. Inskip, K. M. Godfrey, E. M. Dennison, N. Wareham, U. Ekelund, C. Cooper
Meta-analysis of gene-based genome-wide association studies of bone mineral density in Chinese and European subjects
C.-L. Cheung, P.-C. Sham, S.-M. Xiao, C. H. Bow, A. W.-C. Kung
Quantitative ultrasound of the heel and fracture risk assessment: an updated meta-analysis
A. Moayyeri, J. E. Adams, R. A. Adler, M.-A. Krieg, D. Hans, J. Compston, E. M. Lewiecki
Relationship of femoral neck areal bone mineral density to volumetric bone mineral density, bone size, and femoral strength in men and women
B. Srinivasan, D. L. Kopperdahl, S. Amin, E. J. Atkinson, J. Camp, R. A. Robb, B. L. Riggs, E. S. Orwoll, L. J. Melton III, T. M. Keaveny, S. Khosla
Combination of texture analysis and bone mineral density improves the prediction of fracture load in human femurs
T. Le Corroller, J. Halgrin, M. Pithioux, D. Guenoun, P. Chabrand, P. Champsaur
Premenopausal women with idiopathic low-trauma fractures and/or low bone mineral density
A. Cohen, R. R. Recker, J. Lappe, D. W. Dempster, S. Cremers, D. J. McMahon, E. M. Stein, J. Fleischer, C. J. Rosen, H. Rogers, R. B. Staron, J. LeMaster, E. Shane
Pattern of use of DXA scans in men: a cross-sectional, population-based study
M. Frost, C. Gudex, K. H. Rubin, K. Brixen, B. Abrahamsen
Assessment of health claims in the field of bone: a view of the Group for the Respect of Ethics and Excellence in Science (GREES)
O. Bruyère, R. Rizzoli, V. Coxam, B. Avouac, T. Chevalier, V. Fabien-Soulé, J. A. Kanis, J.-M. Kaufman, Y. Tsouderos, J.-Y. Reginster
The effect of high-dose vitamin D on bone mineral density and bone turnover markers in postmenopausal women with low bone mass—a randomized controlled 1-year trial
G. Grimnes, R. Joakimsen, Y. Figenschau, P. A. Torjesen, B. Almås, R. Jorde
A reappraisal of generic bisphosphonates in osteoporosis
J. A. Kanis, J.-Y. Reginster, J.-M. Kaufman, J.-D. Ringe, J. D. Adachi, M. Hiligsmann, R. Rizzoli, C. Cooper
GRAND: the German retrospective cohort analysis on compliance and persistence and the associated risk of fractures in osteoporotic women treated with oral bisphosphonates
P. Hadji, V. Claus, V. Ziller, M. Intorcia, K. Kostev, T. Steinle
Alendronate and atrial fibrillation: a meta-analysis of randomized placebo-controlled clinical trials
E. Barrett-Connor, A. S. Swern, C. M. Hustad, H. G. Bone, U. A. Liberman, S. Papapoulos, H. Wang, A. de Papp, A. C. Santora
Use of bisphosphonate and risk of atrial fibrillation in older women with osteoporosis
C. W. Rhee, J. Lee, S. Oh, N. K. Choi, B. J. Park
Erratum to: Use of bisphosphonate and risk of atrial fibrillation in older women with osteoporosis
C. W. Rhee, J. Lee, S. Oh, N. K. Choi, B. J. Park
Effect of monthly ibandronate on hip structural geometry in men with low bone density
H. K. Genant, E. M. Lewiecki, T. Fuerst, M. Fries
Efficacy and safety of a novel delayed-release risedronate 35 mg once-a-week tablet
M. R. McClung, P. D. Miller, J. P. Brown, J. Zanchetta, M. A. Bolognese, C. L. Benhamou, A. Balske, D. E. Burgio, J. Sarley, L. K. McCullough, R. R. Recker
Vertebral fracture efficacy during risedronate therapy in patients using proton pump inhibitors
C. Roux, J. L. Goldstein, X. Zhou, A. Klemes, R. Lindsay
Risedronate in adults with osteogenesis imperfecta type I: increased bone mineral density and decreased bone turnover, but high fracture rate persists
L. A. Bradbury, S. Barlow, F. Geoghegan, R. A. Hannon, S. L. Stuckey, J. A. H. Wass, R. G. G. Russell, M. A. Brown, E. L. Duncan
The effect of prior bisphosphonate therapy on the subsequent therapeutic effects of strontium ranelate over 2 years
E. T. Middleton, S. A. Steel, M. Aye, S. M. Doherty
Effects of strontium ranelate and alendronate on bone microstructure in women with osteoporosis
R. Rizzoli, R. D. Chapurlat, J.-M. Laroche, M. A. Krieg, T. Thomas, I. Frieling, S. Boutroy, A. Laib, O. Bock, D. Felsenberg
Final results of the DAPS (Denosumab Adherence Preference Satisfaction) study: a 24-month, randomized, crossover comparison with alendronate in postmenopausal women
N. Freemantle, S. Satram-Hoang, E.-T. Tang, P. Kaur, D. Macarios, S. Siddhanti, J. Borenstein, D. L. Kendler
Infections in postmenopausal women with osteoporosis treated with denosumab or placebo: coincidence or causal association?
N. B. Watts, C. Roux, J. F. Modlin, J. P. Brown, A. Daniels, S. Jackson, S. Smith, D. J. Zack, L. Zhou, A. Grauer, S. Ferrari
Balicatib, a cathepsin K inhibitor, stimulates periosteal bone formation in monkeys
C. Jerome, M. Missbach, R. Gamse
Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled study
S. L. Silverman, A. A. Chines, D. L. Kendler, A. W. C. Kung, C. S. Teglbjærg, D. Felsenberg, N. Mairon, G. D. Constantine, J. D. Adachi
Selective serotonin reuptake inhibitor treatment and risk of fractures: a meta-analysis of cohort and case–control studies
Q. Wu, A. F. Bencaz, J. G. Hentz, M. D. Crowell
Deletion of estrogen receptor beta accelerates early stage of bone healing in a mouse osteotomy model
Y.-X. He, Z. Liu, X.-H. Pan, T. Tang, B.-S. Guo, L.-Z. Zheng, X.-H. Xie, X.-L. Wang, K.-M. Lee, G. Li, Y.-P. Cao, L. Wei, Y. Chen, Z.-J. Yang, L.-K. Hung, L. Qin, G. Zhang
High fracture probability with FRAX® usually indicates densitometric osteoporosis: implications for clinical practice
W. D. Leslie, S. R. Majumdar, L. M. Lix, H. Johansson, A. Oden, E. McCloskey, J. A. Kanis
Validation of cross-sectional studies with long-term longitudinal studies
C. Cure-Cure, P. Cure